EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut microbiota and metabolomic profile changes play critical roles in tacrolimus-induced diabetes in rats

Zhenwei Jiang, Minyan Qian, Zeng Zhen, Xuping Yang, Caomei Xu, Li'an Zuo, Jingting Jiang, Wenting Zhang, Nan Hu

Frontiers in Cellular and Infection Microbiology · 17.09.2024 · 14

DOI: 10.3389/fcimb.2024.1436477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 17.09.2024. Verfasst von Zhenwei Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, Changzhou, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Rats, Sprague-Dawley, Tacrolimus, Metabolomics. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Hyperglycemia is one of the adverse effects of tacrolimus (TAC), but the underlying mechanism is not fully identified. We used multi-omics analysis to evaluate the changes in the gut microbiota and metabolic profile of rats with TAC-induced diabetes.

Methods

To establish a diabetic animal model, Sprague Dawley rats were divided randomly into two groups. Those in the TAC group received intraperitoneal injections of TAC (3 mg/kg) for 8 weeks, and those in the CON group served as the control. 16S rRNA sequencing was used to analyze fecal microbiota. The metabolites of the two groups were detected and analyzed by nontargeted and targeted metabolomics, including amino acids (AAs), bile acids (BAs), and short-chain fatty acids (SCFAs).

Results

The rats treated with TAC exhibited hyperglycemia as well as changes in the gut microbiota and metabolites. Specifically, their gut microbiota had significantly higher abundances of Escherichia-Shigella , Enterococcus , and Allobaculum , and significantly lower abundances of Ruminococcus , Akkermansia , and Roseburia . In addition, they had significantly reduced serum levels of AAs including asparagine, aspartic acid, glutamic acid, and methionine. With respect to BAs, they had significantly higher serum levels of taurocholic acid (TCA), and glycochenodeoxycholic acid (GCDCA), but significantly lower levels of taurodeoxycholic acid (TDCA) and tauroursodeoxycholic acid (TUDCA). There were no differences in the levels of SCFAs between the two groups. Correlations existed among glucose metabolism indexes (fasting blood glucose and fasting insulin), gut microbiota ( Ruminococcus and Akkermansia ), and metabolites (glutamic acid, hydroxyproline, GCDCA, TDCA, and TUDCA).

Conclusions

Both AAs and BAs may play crucial roles as signaling molecules in the regulation of TAC-induced diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeRats, Sprague-DawleyTacrolimusMetabolomicsFecesRNA, Ribosomal, 16SAmino AcidsAnimalsRatsMaleDiabetes Mellitus, ExperimentalBile Acids and SaltsFatty Acids, VolatileMetabolomeDisease Models, AnimalHyperglycemiaBacteriaBlood GlucoseImmunosuppressive Agents

Stichwörter der Autor:innen

amino acidsbile acidsdiabetesgut microbiotametabolomicsshort chain fatty acidstacrolimus

Substanzen

TacrolimusRNA, Ribosomal, 16SAmino AcidsBile Acids and SaltsFatty Acids, VolatileBlood GlucoseImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pharmacy, The Third Affiliated Hospital of Soochow University/The First People's Hospital of Changzhou, Changzhou, China.
  • Changzhou Key Laboratory of Human Use Experience Research & Transformation of Menghe Medical School, Changzhou Hospital Affiliated to Nanjing University of Chinese Medicine, Changzhou, China.
  • Department of Tumor Biological Treatment, The Third Affiliated Hospital of Soochow University, Changzhou, China.
  • Pediatric Central Laboratory, Affiliated Changzhou Children's Hospital of Nantong University, Changzhou, China.

Zitieren

APA

Jiang, Z., Qian, M., Zhen, Z., Yang, X., Xu, C., Zuo, L., Jiang, J., Zhang, W., & Hu, N. (2024). Gut microbiota and metabolomic profile changes play critical roles in tacrolimus-induced diabetes in rats. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1436477

Vancouver

Jiang Z, Qian M, Zhen Z, Yang X, Xu C, Zuo L, et al. Gut microbiota and metabolomic profile changes play critical roles in tacrolimus-induced diabetes in rats. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1436477

BibTeX
@article{Jiang2024,
  author = {Jiang, Zhenwei and Qian, Minyan and Zhen, Zeng and Yang, Xuping and Xu, Caomei and Zuo, Li'an and Jiang, Jingting and Zhang, Wenting and Hu, Nan},
  title = {Gut microbiota and metabolomic profile changes play critical roles in tacrolimus-induced diabetes in rats},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1436477}
}
Kostenlos starten →